Welcome to the information site on computational systems biology services and solutions by Bayer provided to the healthcare industry.

To gain comprehensive understanding about biological systems, their interaction with pharmaceuticals and the complex dynamical processes involved, Bayer relies on mechanistic modeling.

With the aim of  supporting decision making along the pharma research and development process, we offer software products for predictive simulation of drug behavior and modeling of cellular pathways, integrating many years of in-house and external market experience.

To access a selection of our publications and conference posters offering more detailed information on our work, please follow the link to our Literature pages. If you would like to know more about how we pursue our research mission statement - to perform frontier research and transform results into cutting edge products to support drug development - please check our Research section.

Our Software Platform

Our software products are fully integrated into one Computational Systems Biology Software Suite, representing a user-friendly and flexible software package.

» More

December 19, 2016

New publications regarding PBPK modeling: Elderly, Isoniazid, DDI and Diabetes. In addition: A white paper regarding good practices in drug discovery and development

» More

October 18, 2016

Published in CPT Pharmacometrics & Systems Pharmacology: Applied Concepts in PBPK modeling: How to build a PBPK/PD model

» More

September 15, 2016

New Version Release: Computational Systems Biology Software Suite Version 6.3

» More

» All News

October 27, 2016

ACoP Meeting 2016, October 23-26, Seattle, WA, USA

» More

September 24, 2016

ACCP Annual Meeting 2016, September 25-27, Bethesda, MD, USA

» More

September 06, 2016

APS 2016, September 5 - 7, University of Strathclyde, Glasgow

» More

» All Events